— Know what they know.
Not Investment Advice
Also trades as: 0QAH.L (LSE) · $vol 5M · 6MK.DE (XETRA) · $vol 0M · MRK.TO (TSX) · $vol 0M · MRK.PA (PAR) · $vol 0M

MRK NYSE

Merck & Co., Inc.
1W: -3.0% 1M: -4.3% 3M: +13.8% YTD: +35.6% 1Y: +61.5% 3Y: +49.1% 5Y: +123.8%
$144.30
+0.49 (+0.34%)
 
Weekly Expected Move ±2.6%
$137 $141 $144 $148 $152
NYSE · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 53 · $356.4B mcap · 2.47B float · 0.430% daily turnover · Short 29% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
60.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 6.1%  ·  5Y Avg: 16.2%
Cost Advantage
55
Intangibles
67
Switching Cost
54
Network Effect
45
Scale ★
85
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MRK has a Narrow competitive edge (60.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 6.1% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$116
Low
$160
Avg Target
$180
High
Based on 18 analysts since Aug 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 26Hold: 11Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$155.04
Analysts23
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-29 Scotiabank — $155 $180 +25 +22.3% $147.15
2026-09-11 Berenberg Bank Luisa Hector $90 $137 +47 -5.3% $144.71
2026-09-10 HSBC — $150 $172 +22 +16.5% $147.60
2026-09-09 Leerink Partners — $110 $161 +51 +8.4% $148.49
2026-09-08 Guggenheim Vamil Divan $146 $170 +24 +13.1% $150.34
2026-09-04 Wells Fargo — $150 $170 +20 +11.6% $152.34
2026-08-25 Argus Research Jasper Hellweg $145 $170 +25 +10.7% $153.61
2026-08-25 Wolfe Research Alexandria Hammond $135 $180 +45 +19.5% $150.69
2026-08-21 Goldman Sachs — $133 $160 +27 +7.2% $149.25
2026-08-20 BMO Capital — $142 $170 +28 +13.6% $149.65
2026-08-20 UBS — $150 $175 +25 +15.0% $152.22
2026-08-20 RBC Capital — $142 $150 +8 -1.5% $152.22
2026-08-20 UBS Matthew Weston $130 $150 +20 -1.5% $152.22
2026-08-19 Morgan Stanley — $116 $179 +63 +17.6% $152.22
2026-08-12 Daiwa — Initiated $143 — +9.6% $130.45
2026-08-11 Argus Research Jasper Hellweg $110 $145 +35 +10.8% $130.90
2026-08-05 Morgan Stanley Terence Flynn $112 $116 +4 -11.0% $130.40
2026-08-05 Guggenheim Vamil Divan $145 $146 +1 +14.0% $128.04
2026-07-29 Barclays Emily Field $140 $150 +10 +13.8% $131.84
2026-07-27 Bernstein Courtney Breen $100 $105 +5 -20.7% $132.34
2026-07-13 BMO Capital — $135 $142 +7 +14.4% $124.08
2026-07-13 Guggenheim Vamil Divan $140 $145 +5 +17.4% $123.54
2026-07-06 HSBC Rajesh Kumar $120 $150 +30 +19.0% $126.05
2026-06-30 Jefferies — $148 $141 -7 +9.0% $129.38
2026-06-29 Scotiabank — $136 $155 +19 +19.8% $129.38
2026-06-02 Guggenheim Vamil Divan $122 $140 +18 +21.5% $115.21
2026-05-01 Morgan Stanley Terence Flynn $102 $112 +10 -0.4% $112.47
2026-03-12 Wells Fargo Mohit Bansal $140 $150 +10 +29.1% $116.22
2026-02-24 RBC Capital Trung Huynh Initiated $142 — +14.6% $123.93
2026-02-13 Deutsche Bank James Shin Initiated $150 — +23.4% $121.53
2026-02-04 Goldman Sachs Asad Haider $120 $133 +13 +14.8% $115.86
2026-02-04 BMO Capital — $130 $135 +5 +16.5% $115.86
2026-02-04 Bernstein — $110 $100 -10 -13.7% $115.86
2026-02-03 Scotiabank — $120 $136 +16 +16.9% $116.37
2026-01-27 Cantor Fitzgerald — $135 $116 -19 +8.0% $107.40
2026-01-08 Wolfe Research — $94 $135 +41 +24.3% $108.59
2026-01-07 UBS — $136 $130 -6 +17.2% $110.96
2025-12-18 BMO Capital — $82 $130 +48 +31.0% $99.21
2025-12-12 Morgan Stanley — $100 $102 +2 +1.9% $100.06
2025-12-10 HSBC Rajesh Kumar Initiated $120 — +23.9% $96.89
2025-12-05 Guggenheim — Initiated $122 — +20.9% $100.89
2025-12-04 Scotiabank Louise Chen Initiated $120 — +17.8% $101.88
2025-12-02 Goldman Sachs Asad Haider $93 $120 +27 +17.8% $101.83
2025-11-03 Morgan Stanley Terence Flynn $98 $100 +2 +18.1% $84.65
2025-09-17 Berenberg Bank Luisa Hector Initiated $90 — +10.9% $81.14
2025-07-10 Morgan Stanley Terence Flynn $106 $98 -8 +16.1% $84.39
2025-04-25 BMO Capital Evan Seigerman $136 $82 -54 -0.9% $82.74
2025-02-04 Morgan Stanley Terence Flynn $99 $106 +7 +16.8% $90.74
2024-12-02 Bernstein Courtney Breen Initiated $110 — +9.2% $100.69
2024-11-15 Jefferies Akash Tewari $147 $148 +1 +50.5% $98.36

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
Oct 02, 2026
DCF
4
ROE
3
ROA
5
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MRK receives an overall rating of B-. Strongest factors: DCF (4/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-08-14 C+ B-
2026-08-10 B C+
2026-05-14 B+ B
2026-05-05 C B+
2026-05-01 A- C
2026-04-01 B+ A-
2026-03-18 A- B+
2026-02-26 B A-
2026-02-04 A- B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 49 Grade C
Profitability
28
Balance Sheet
45
Earnings Quality
54
Growth
24
Value
36
Momentum
58
Safety
90
Cash Flow
71
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. MRK scores highest in Safety (90/100) and lowest in Growth (24/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.63
Safe Zone
Piotroski F-Score
4/9
✓ ✓ ✗ ✓ ✗ ✗ ✓ ✗ ✗
Beneish M-Score
-2.94
Unlikely Manipulator
Ohlson O-Score
-7.82
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A-
Score: 67.8/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 6.29x
Accruals: -13.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MRK scores 3.63, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MRK scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MRK's score of -2.94 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MRK's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MRK receives an estimated rating of A- (score: 67.8/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). MRK's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
114.52x
PEG
-1.42x
P/S
5.37x
P/B
8.51x
P/FCF
19.78x
P/OCF
15.91x
EV/EBITDA
26.17x
EV/Revenue
5.48x
EV/EBIT
50.54x
EV/FCF
22.69x
Earnings Yield
1.00%
FCF Yield
5.06%
Shareholder Yield
2.74%
Graham Number
$22.13
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 114.5x earnings, MRK is priced for high growth expectations. Graham's intrinsic value formula yields $22.13 per share, 552% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.533
NI / EBT
×
Interest Burden
0.825
EBT / EBIT
×
EBIT Margin
0.108
EBIT / Rev
×
Asset Turnover
0.538
Rev / Assets
×
Equity Multiplier
2.720
Assets / Equity
=
ROE
7.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MRK's ROE of 7.0% is driven by Asset Turnover (0.538), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.53 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
1.56%
Fair P/E
11.62x
Intrinsic Value
$14.92
Price/Value
8.61x
Margin of Safety
-761.35%
Premium
761.35%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with MRK's realized 1.6% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. MRK trades at a 761% premium to its adjusted intrinsic value of $14.92, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 11.6x compares to the current market P/E of 114.5x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$144.31
Median 1Y
$156.36
5th Pctile
$105.55
95th Pctile
$231.39
Ann. Volatility
25.0%
Analyst Target
$155.04
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Robert M. Davis
Chairman, Chief Executive Officer and President
$1,645,302 $12,102,838 $20,797,845
Dean Li, M.D.,
Ph.D. Executive Vice President and President, Merck Research Laboratories
$1,460,000 $4,296,864 $8,892,881
Caroline Litchfield Financial
Vice President and Chief Financial Officer
$1,173,214 $3,580,681 $7,514,085
Jennifer Zachary Counsel
ve Vice President and General Counsel
$1,062,217 $2,685,571 $5,860,578
Sanat Chattopadhyay President,
Vice President and President, Merck Manufacturing Division
$982,170 $2,363,261 $5,408,408

CEO Pay Ratio

147:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $20,797,845
Avg Employee Cost (SGA/emp): $141,467
Employees: 75,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
75,000
0.0% YoY
Revenue / Employee
$866,813
Rev: $65,011,000,000
Profit / Employee
$243,387
NI: $18,254,000,000
SGA / Employee
$141,467
Avg labor cost proxy
R&D / Employee
$207,933
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 22.2% 41.1% 41.8% 43.3% 38.0% 34.5% 29.7% 7.6% 10.8% 0.9% 5.3% 33.4% 28.3% 40.8% 39.3% 35.4% 39.5% 36.9% 19.0% 7.0% 6.98%
ROA 7.9% 13.2% 14.4% 16.8% 15.2% 13.5% 12.2% 2.9% 4.3% 0.3% 2.2% 12.7% 10.8% 15.3% 15.8% 14.3% 15.4% 14.4% 7.3% 2.6% 2.57%
ROIC 11.6% 18.2% 22.2% 26.9% 26.5% 24.9% 21.0% 5.3% 7.5% 0.9% 4.2% 20.7% 18.4% 24.5% 23.9% 22.4% 26.1% 23.7% 14.1% 6.1% 6.10%
ROCE 12.6% 17.9% 19.7% 23.1% 21.1% 20.5% 19.1% 7.9% 10.2% 3.7% 6.3% 19.0% 17.0% 23.9% 23.8% 22.3% 22.9% 20.7% 12.5% 7.1% 7.06%
Gross Margin 73.8% 71.3% 66.2% 71.1% 73.7% 71.9% 72.9% 73.2% 73.3% 73.3% 77.6% 76.8% 75.5% 75.5% 78.0% 77.5% 77.7% 70.5% 81.9% 73.5% 73.54%
Operating Margin 37.4% 27.7% 35.4% 34.7% 27.4% 25.2% 26.3% -33.3% 36.8% -11.7% 36.5% 38.0% 23.9% 27.8% 38.2% 35.1% 37.9% 37.7% -11.6% -4.1% -4.11%
Net Margin 34.7% 27.8% 27.1% 27.0% 21.7% 21.8% 19.5% -39.7% 29.7% -8.4% 30.2% 33.9% 19.0% 24.0% 32.7% 28.0% 33.5% 18.2% -26.0% -8.0% -8.04%
EBITDA Margin 47.3% 36.6% 39.1% 38.8% 32.0% 33.6% 33.7% -27.6% 43.5% -5.3% 44.1% 46.2% 33.7% 36.5% 47.1% 40.6% 47.6% 38.6% -12.4% 8.6% 8.58%
FCF Margin 17.5% 19.8% 23.7% 25.2% 25.9% 24.8% 19.5% 18.6% 22.2% 15.2% 18.0% 21.0% 23.5% 28.2% 26.7% 23.1% 20.3% 19.0% 21.5% 24.2% 24.16%
OCF Margin 27.4% 29.0% 31.6% 33.0% 33.4% 32.2% 27.1% 25.9% 29.0% 21.6% 24.0% 26.7% 28.9% 33.5% 32.7% 29.1% 26.6% 25.4% 27.2% 30.0% 30.03%
ROE 3Y Avg snapshot only 24.19%
ROE 5Y Avg snapshot only 23.79%
ROA 3Y Avg snapshot only 9.53%
ROIC 3Y Avg snapshot only 9.68%
ROIC Economic snapshot only 5.72%
Cash ROA snapshot only 15.38%
Cash ROIC snapshot only 22.51%
CROIC snapshot only 18.11%
NOPAT Margin snapshot only 8.13%
Pretax Margin snapshot only 8.95%
R&D / Revenue snapshot only 43.66%
SGA / Revenue snapshot only 16.62%
SBC / Revenue snapshot only 1.03%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 23.18 13.16 13.09 12.56 13.00 17.77 19.14 87.11 52.98 715.66 137.43 21.78 22.71 14.23 12.67 11.91 10.92 14.35 33.28 100.11 114.524
P/S Ratio 3.50 3.53 3.44 3.64 3.37 4.35 4.31 4.65 4.12 4.35 5.16 4.79 4.37 3.80 3.46 3.07 3.24 4.03 4.53 4.78 5.367
P/B Ratio 4.66 4.50 4.54 4.82 4.46 5.61 5.32 7.00 5.92 6.95 7.85 6.86 6.20 5.26 4.57 3.99 4.01 4.98 6.48 7.58 8.507
P/FCF 20.03 17.78 14.53 14.46 13.01 17.54 22.14 25.03 18.54 28.57 28.71 22.75 18.59 13.46 12.96 13.27 15.93 21.19 21.07 19.78 19.775
P/OCF 12.75 12.17 10.87 11.02 10.08 13.51 15.91 17.98 14.20 20.08 21.47 17.92 15.10 11.35 10.58 10.54 12.18 15.90 16.62 15.91 15.909
EV/EBITDA 15.19 11.08 10.40 9.96 10.06 12.98 13.50 29.70 21.94 42.04 38.47 15.82 15.56 10.43 9.46 8.87 8.35 10.54 18.01 26.17 26.168
EV/Revenue 3.84 4.07 3.86 4.02 3.69 4.67 4.66 5.17 4.56 4.83 5.63 5.21 4.74 4.18 3.86 3.49 3.60 4.59 5.19 5.48 5.481
EV/EBIT 20.87 13.50 12.56 11.84 12.24 15.90 16.66 47.05 31.72 95.68 67.53 19.74 20.00 12.65 11.49 10.87 10.01 13.28 26.89 50.54 50.536
EV/FCF 22.00 20.53 16.32 15.96 14.27 18.82 23.95 27.85 20.52 31.76 31.30 24.76 20.18 14.82 14.47 15.09 17.71 24.10 24.14 22.69 22.687
Earnings Yield 4.3% 7.6% 7.6% 8.0% 7.7% 5.6% 5.2% 1.1% 1.9% 0.1% 0.7% 4.6% 4.4% 7.0% 7.9% 8.4% 9.2% 7.0% 3.0% 1.0% 1.00%
FCF Yield 5.0% 5.6% 6.9% 6.9% 7.7% 5.7% 4.5% 4.0% 5.4% 3.5% 3.5% 4.4% 5.4% 7.4% 7.7% 7.5% 6.3% 4.7% 4.7% 5.1% 5.06%
EV/OCF snapshot only 18.251
EV/Gross Profit snapshot only 7.219
Acquirers Multiple snapshot only 35.914
Shareholder Yield snapshot only 2.74%
Graham Number snapshot only $22.13
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.31 1.27 1.40 1.39 1.46 1.47 1.44 1.28 1.38 1.25 1.25 1.47 1.36 1.36 1.41 1.42 1.66 1.54 1.30 1.32 1.323
Quick Ratio 0.97 1.02 1.14 1.15 1.22 1.23 1.19 1.03 1.12 1.00 0.99 1.22 1.15 1.15 1.16 1.17 1.44 1.30 1.06 1.10 1.099
Debt/Equity 0.74 0.91 0.78 0.73 0.68 0.70 0.66 0.95 0.85 0.97 0.85 0.87 0.86 0.83 0.72 0.72 0.80 0.96 1.07 1.29 1.286
Net Debt/Equity 0.46 0.69 0.56 0.50 0.43 0.41 0.43 0.79 0.63 0.78 0.71 0.61 0.53 0.53 0.53 0.55 0.45 0.68 0.95 1.12 1.115
Debt/Assets 0.28 0.33 0.30 0.30 0.28 0.29 0.29 0.35 0.33 0.34 0.32 0.34 0.32 0.33 0.30 0.30 0.32 0.37 0.38 0.42 0.415
Debt/EBITDA 2.19 1.93 1.59 1.37 1.41 1.50 1.54 3.64 2.83 5.25 3.81 1.84 1.98 1.49 1.34 1.41 1.50 1.79 2.60 3.87 3.871
Net Debt/EBITDA 1.36 1.48 1.14 0.93 0.89 0.88 1.02 3.01 2.12 4.22 3.18 1.28 1.22 0.96 0.98 1.07 0.84 1.27 2.29 3.36 3.358
Interest Coverage 10.91 18.20 19.53 21.86 18.99 18.09 16.85 6.42 7.95 2.65 4.24 13.30 11.95 16.69 16.74 16.02 18.14 16.54 12.15 5.71 5.709
Equity Multiplier 2.61 2.77 2.61 2.48 2.41 2.37 2.30 2.70 2.59 2.84 2.62 2.58 2.64 2.53 2.38 2.40 2.50 2.60 2.80 3.10 3.095
Cash Ratio snapshot only 0.258
Debt Service Coverage snapshot only 11.026
Cash to Debt snapshot only 0.132
FCF to Debt snapshot only 0.298
Defensive Interval snapshot only 178.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.52 0.49 0.55 0.58 0.59 0.55 0.54 0.55 0.55 0.56 0.57 0.58 0.56 0.57 0.58 0.55 0.52 0.51 0.54 0.54 0.538
Inventory Turnover 1.89 2.37 2.20 2.52 2.56 2.94 2.74 2.75 2.74 2.63 2.54 2.49 2.47 2.44 2.37 2.28 2.31 2.45 2.39 2.50 2.500
Receivables Turnover 5.61 6.08 5.98 6.54 6.53 6.35 5.72 5.64 5.97 6.07 5.64 5.51 5.80 6.22 5.77 5.42 5.47 5.89 5.71 5.45 5.448
Payables Turnover 4.30 3.05 4.08 4.59 5.17 3.92 4.32 4.55 4.68 3.94 4.38 4.44 4.31 3.80 4.13 4.02 3.79 3.69 3.97 4.15 4.148
DSO 65 60 61 56 56 58 64 65 61 60 65 66 63 59 63 67 67 62 64 67 67.0 days
DIO 193 154 166 145 143 124 133 133 133 139 143 146 148 150 154 160 158 149 152 146 146.0 days
DPO 85 120 89 80 71 93 85 80 78 93 83 82 85 96 88 91 96 99 92 88 88.0 days
Cash Conversion Cycle 173 95 137 121 128 89 112 117 116 106 125 130 126 112 129 137 128 112 124 125 125.0 days
Fixed Asset Turnover snapshot only 2.584
Operating Cycle snapshot only 213.0 days
Cash Velocity snapshot only 9.311
Capital Intensity snapshot only 1.952
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 7.9% 8.6% 24.3% 25.7% 23.6% 21.7% 7.2% 2.0% 0.6% 1.4% 6.1% 7.1% 6.5% 6.7% 4.1% 1.8% 1.7% 1.2% 2.8% 4.5% 4.52%
Net Income -37.5% 84.6% 1.0% 2.0% 1.1% 11.3% -8.1% -81.2% -69.8% -97.5% -82.3% 3.4% 1.6% 45.9% 6.6% 19.4% 56.7% 6.6% -48.7% -80.7% -80.66%
EPS -37.5% 85.0% 1.0% 2.0% 1.1% 10.7% -8.6% -81.2% -69.9% -97.5% -82.3% 3.4% 1.6% 46.1% 6.6% 20.9% 59.4% 8.9% -47.5% -80.3% -80.34%
FCF 23.7% 73.5% 96.5% 1.7% 83.1% 52.2% -11.9% -24.8% -13.7% -37.8% -2.0% 21.4% 12.7% 97.9% 54.3% 12.0% -12.1% -31.7% -17.2% 9.1% 9.11%
EBITDA -26.7% 53.9% 85.0% 1.4% 79.3% 19.1% -0.4% -56.0% -43.0% -67.6% -55.0% 1.0% 56.2% 2.7% 1.9% 21.6% 43.8% 9.9% -27.4% -44.4% -44.38%
Op. Income -35.8% 89.0% 1.7% 2.8% 1.5% 38.5% 3.0% -67.0% -56.0% -83.8% -70.2% 1.5% 73.7% 5.8% 3.2% 23.5% 58.1% 19.7% -19.7% -48.8% -48.81%
OCF Growth snapshot only 7.73%
Asset Growth snapshot only 10.45%
Equity Growth snapshot only -14.41%
Debt Growth snapshot only 52.27%
Shares Change snapshot only -1.63%
Dividend Growth snapshot only 5.04%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 4.6% 4.8% 7.8% 8.8% 8.7% 8.2% 6.4% 8.5% 10.3% 10.3% 12.2% 11.2% 9.8% 9.6% 5.8% 3.6% 2.9% 3.1% 4.3% 4.5% 4.47%
Revenue 5Y 3.6% 4.1% 6.2% 7.4% 8.2% 8.1% 7.3% 7.2% 7.3% 7.3% 7.3% 7.1% 6.6% 6.5% 5.9% 6.9% 7.8% 7.7% 8.6% 7.9% 7.90%
EPS 3Y 31.4% 29.7% 20.1% 21.7% 18.4% 14.0% 8.6% -33.3% -26.4% -62.8% -31.1% 35.0% 19.0% 9.4% 7.2% 0.0% 8.3% 8.8% -10.9% 1.6% 1.56%
EPS 5Y 7.6% 29.5% 28.9% 28.7% 41.9% 45.2% 54.4% 19.8% 7.7% -42.9% -22.4% 8.3% 5.7% 11.9% 11.6% 9.6% 10.9% 21.4% 5.5% -10.2% -10.16%
Net Income 3Y 29.1% 28.0% 19.1% 21.0% 17.9% 13.8% 8.7% -33.3% -26.3% -62.8% -31.0% 35.1% 19.1% 9.5% 7.1% -0.3% 7.6% 7.9% -11.8% 0.7% 0.66%
Net Income 5Y 5.6% 27.2% 26.7% 26.7% 39.9% 43.4% 52.5% 18.3% 6.6% -43.3% -22.8% 8.0% 5.5% 11.7% 11.4% 9.4% 10.6% 20.9% 4.9% -10.6% -10.65%
EBITDA 3Y -3.4% 8.3% 8.7% 11.8% 10.7% 10.0% 6.1% -14.4% -9.2% -15.9% -6.1% 29.1% 16.8% 12.8% 9.1% 2.8% 8.5% 9.9% -1.8% 11.1% 11.10%
EBITDA 5Y -2.0% 10.6% 13.1% 15.2% 20.0% 12.3% 12.3% -1.5% -1.6% -13.3% -10.4% 4.5% 3.8% 9.9% 9.3% 9.1% 10.9% 19.4% 11.8% 7.8% 7.81%
Gross Profit 3Y 4.9% 6.8% 8.7% 9.1% 8.8% 8.6% 7.5% 10.0% 11.2% 13.3% 16.4% 15.4% 13.9% 11.8% 8.6% 6.6% 6.0% 5.6% 6.4% 5.9% 5.87%
Gross Profit 5Y 4.9% 6.2% 7.5% 8.2% 9.0% 9.0% 8.6% 8.8% 9.0% 8.9% 9.0% 8.7% 8.2% 8.4% 7.7% 8.8% 9.5% 10.3% 11.8% 10.5% 10.51%
Op. Income 3Y -3.1% 13.9% 12.6% 16.1% 14.6% 14.3% 8.7% -18.5% -11.3% -24.9% -5.6% 46.6% 23.5% 15.3% 8.5% 0.8% 6.5% 9.8% -0.2% 16.7% 16.68%
Op. Income 5Y -2.3% 17.0% 20.3% 21.8% 33.9% 21.4% 22.4% 2.2% -0.2% -19.9% -15.2% 5.3% 2.8% 10.6% 9.7% 10.9% 13.9% 28.2% 22.9% 14.8% 14.79%
FCF 3Y -2.3% 5.2% 15.3% 22.4% 19.3% 13.8% 8.0% 5.0% 25.0% 18.0% 19.3% 34.8% 21.2% 23.3% 10.1% 0.7% -5.1% -5.6% 7.8% 14.0% 14.05%
FCF 5Y -2.5% 2.0% 13.4% 11.1% 28.6% 26.4% 16.2% 15.8% 8.0% 1.9% 5.8% 10.9% 10.6% 12.7% 13.8% 9.5% 14.1% 17.3% 16.8% 24.5% 24.54%
OCF 3Y 4.9% 8.9% 15.4% 20.5% 17.2% 12.4% 7.0% 4.8% 15.9% 8.3% 9.2% 16.9% 11.8% 15.0% 6.9% -0.6% -4.7% -4.8% 4.5% 9.8% 9.82%
OCF 5Y 3.5% 6.3% 15.0% 13.1% 26.6% 24.3% 16.5% 15.4% 8.7% 3.6% 5.9% 9.1% 8.3% 9.8% 10.3% 7.2% 9.1% 9.9% 9.6% 13.8% 13.80%
Assets 3Y 3.2% 8.5% 9.0% 8.4% 8.7% 9.0% 8.3% 4.9% 5.9% 5.2% 5.2% 7.5% 7.9% 3.5% 2.6% 3.1% 6.6% 7.8% 6.1% 7.5% 7.51%
Assets 5Y -1.0% 2.1% 2.0% 2.9% 3.2% 4.4% 4.6% 4.2% 4.6% 5.2% 5.1% 6.1% 7.1% 6.8% 6.3% 5.3% 7.6% 8.4% 7.2% 7.4% 7.44%
Equity 3Y 3.4% 12.7% 14.1% 16.1% 18.3% 21.1% 21.4% 11.9% 12.2% 14.1% 14.4% 9.4% 7.5% 6.6% 5.7% 4.2% 5.3% 4.6% -0.7% 2.7% 2.72%
Book Value 3Y 5.2% 14.1% 15.1% 16.8% 18.8% 21.3% 21.3% 11.8% 12.1% 13.9% 14.4% 9.3% 7.5% 6.6% 5.8% 4.6% 5.9% 5.4% 0.4% 3.6% 3.64%
Dividend 3Y 4.2% 3.4% 3.0% 2.7% 2.4% 2.1% 1.9% 2.0% 2.0% 1.8% 1.9% 1.8% 1.7% 1.7% 1.8% 2.0% 2.2% 2.2% 2.3% 2.0% 2.00%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.83 0.84 0.66 0.73 0.75 0.77 0.77 0.84 0.85 0.86 0.87 0.87 0.87 0.88 1.00 0.93 0.88 0.89 0.92 0.93 0.927
Earnings Stability 0.41 0.75 0.66 0.52 0.71 0.86 0.70 0.06 0.06 0.01 0.03 0.01 0.00 0.02 0.04 0.15 0.18 0.18 0.01 0.00 0.000
Margin Stability 0.96 0.96 0.97 0.98 0.98 0.97 0.97 0.97 0.97 0.96 0.96 0.96 0.96 0.97 0.96 0.96 0.96 0.95 0.94 0.95 0.949
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.85 0.50 0.50 0.50 0.50 0.95 0.97 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.92 0.50 0.97 0.81 0.50 0.500
Earnings Smoothness 0.54 0.41 0.33 0.01 0.28 0.89 0.92 0.00 0.00 0.00 0.00 0.00 0.10 0.00 0.00 0.82 0.56 0.94 0.36 0.00 0.000
ROE Trend -0.17 0.01 0.02 0.11 0.05 0.01 -0.03 -0.19 -0.16 -0.32 -0.26 0.08 0.05 0.21 0.19 0.14 0.17 0.16 -0.01 -0.25 -0.249
Gross Margin Trend -0.03 0.03 0.02 0.02 0.01 0.01 0.04 0.04 0.04 0.02 0.03 0.04 0.04 0.04 0.03 0.02 0.03 0.01 0.02 -0.00 -0.000
FCF Margin Trend 0.00 0.03 0.07 0.09 0.10 0.09 0.00 0.00 0.01 -0.07 -0.04 -0.01 -0.01 0.08 0.08 0.03 -0.03 -0.03 -0.01 0.02 0.021
Sustainable Growth Rate 2.1% 20.3% 22.0% 25.5% 20.8% 17.8% 13.5% -10.1% -6.4% -16.9% -12.0% 14.8% 10.3% 22.1% 21.4% 18.1% 22.7% 20.4% 1.5% -11.3% -11.27%
Internal Growth Rate 0.8% 7.0% 8.2% 11.0% 9.1% 7.5% 5.8% — — — — 5.9% 4.1% 9.0% 9.4% 7.8% 9.7% 8.6% 0.6% — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.82 1.08 1.20 1.14 1.29 1.32 1.20 4.85 3.73 35.63 6.40 1.22 1.50 1.25 1.20 1.13 0.90 0.90 2.00 6.29 6.293
FCF/OCF 0.64 0.68 0.75 0.76 0.77 0.77 0.72 0.72 0.77 0.70 0.75 0.79 0.81 0.84 0.82 0.79 0.76 0.75 0.79 0.80 0.804
FCF/Net Income snapshot only 5.062
OCF/EBITDA snapshot only 1.434
CapEx/Revenue 10.0% 9.1% 8.0% 7.9% 7.5% 7.4% 7.6% 7.3% 6.8% 6.4% 6.1% 5.7% 5.4% 5.3% 6.0% 6.0% 6.3% 6.3% 5.7% 5.9% 5.87%
CapEx/Depreciation snapshot only 0.581
Accruals Ratio -0.06 -0.01 -0.03 -0.02 -0.04 -0.04 -0.02 -0.11 -0.12 -0.12 -0.12 -0.03 -0.05 -0.04 -0.03 -0.02 0.02 0.01 -0.07 -0.14 -0.136
Sloan Accruals snapshot only -0.071
Cash Flow Adequacy snapshot only 1.636
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 3.9% 3.8% 3.6% 3.3% 3.5% 2.7% 2.9% 2.7% 3.0% 2.9% 2.4% 2.6% 2.8% 3.2% 3.6% 4.1% 3.9% 3.1% 2.8% 2.6% 2.36%
Dividend/Share $2.57 $2.61 $2.64 $2.68 $2.72 $2.75 $2.79 $2.85 $2.88 $2.91 $2.96 $3.00 $3.05 $3.09 $3.14 $3.20 $3.25 $3.29 $3.33 $3.36 $3.40
Payout Ratio 90.4% 50.7% 47.3% 41.1% 45.2% 48.3% 54.6% 2.3% 1.6% 20.4% 3.3% 55.6% 63.7% 45.8% 45.5% 49.0% 42.6% 44.8% 92.1% 2.6% 2.62%
FCF Payout Ratio 78.1% 68.4% 52.5% 47.3% 45.3% 47.7% 63.2% 66.8% 55.8% 81.4% 68.3% 58.1% 52.2% 43.3% 46.6% 54.6% 62.1% 66.1% 58.3% 51.7% 51.66%
Total Payout Ratio 1.0% 57.1% 53.2% 44.7% 45.4% 48.3% 55.8% 2.5% 1.8% 24.1% 3.8% 64.6% 73.7% 53.4% 59.0% 69.9% 45.3% 51.8% 1.0% 2.7% 2.74%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.11 0.10 0.10 0.10 0.10 0.09 0.09 0.09 0.09 0.09 0.08 0.08 0.08 0.09 0.09 0.09 0.09 0.07 0.06 0.06 0.059
Buyback Yield 0.5% 0.5% 0.5% 0.3% 0.0% 0.0% 0.1% 0.2% 0.4% 0.5% 0.4% 0.4% 0.4% 0.5% 1.1% 1.8% 0.2% 0.5% 0.3% 0.1% 0.12%
Net Buyback Yield 0.5% 0.5% 0.4% 0.2% -0.1% -0.1% -0.1% 0.1% 0.3% 0.5% 0.4% 0.4% 0.4% 0.5% 1.1% 1.8% 0.2% 0.5% 0.3% 0.0% 0.05%
Total Shareholder Return 4.4% 4.3% 4.1% 3.5% 3.4% 2.6% 2.8% 2.7% 3.3% 3.4% 2.8% 3.0% 3.2% 3.8% 4.6% 5.9% 4.1% 3.6% 3.0% 2.7% 2.66%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.90 0.94 0.90 0.90 0.91 0.88 0.86 0.57 0.62 0.19 0.59 0.90 0.89 0.86 0.86 0.86 0.87 0.87 0.77 0.53 0.533
Interest Burden (EBT/EBIT) 0.91 0.95 0.95 0.95 0.95 0.94 0.94 0.84 0.87 0.62 0.76 0.92 0.92 0.94 0.94 0.94 0.94 0.94 0.92 0.82 0.825
EBIT Margin 0.18 0.30 0.31 0.34 0.30 0.29 0.28 0.11 0.14 0.05 0.08 0.26 0.24 0.33 0.34 0.32 0.36 0.35 0.19 0.11 0.108
Asset Turnover 0.52 0.49 0.55 0.58 0.59 0.55 0.54 0.55 0.55 0.56 0.57 0.58 0.56 0.57 0.58 0.55 0.52 0.51 0.54 0.54 0.538
Equity Multiplier 2.82 3.11 2.91 2.58 2.50 2.55 2.44 2.58 2.49 2.58 2.45 2.64 2.62 2.67 2.49 2.49 2.56 2.57 2.59 2.72 2.720
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $2.84 $5.15 $5.59 $6.53 $6.00 $5.70 $5.11 $1.23 $1.81 $0.14 $0.91 $5.40 $4.78 $6.74 $6.89 $6.53 $7.62 $7.34 $3.61 $1.28 $1.28
Book Value/Share $14.11 $15.06 $16.11 $17.02 $17.49 $18.05 $18.36 $15.24 $16.20 $14.71 $15.87 $17.13 $17.51 $18.23 $19.10 $19.50 $20.76 $21.14 $18.56 $16.96 $16.98
Tangible Book/Share $1.40 $-2.37 $-1.34 $-0.18 $0.76 $1.77 $2.26 $-0.85 $0.34 $-0.64 $0.63 $2.14 $2.28 $3.26 $4.30 $4.86 $5.98 $1.75 $-0.59 $-1.87 $-1.87
Revenue/Share $18.81 $19.21 $21.28 $22.51 $23.20 $23.27 $22.68 $22.97 $23.30 $23.54 $24.14 $24.56 $24.86 $25.25 $25.26 $25.31 $25.71 $26.10 $26.57 $26.90 $26.86
FCF/Share $3.28 $3.81 $5.04 $5.67 $6.00 $5.77 $4.41 $4.26 $5.17 $3.58 $4.34 $5.17 $5.84 $7.12 $6.73 $5.86 $5.22 $4.97 $5.71 $6.50 $6.50
OCF/Share $5.16 $5.57 $6.73 $7.44 $7.75 $7.49 $6.14 $5.94 $6.75 $5.09 $5.80 $6.56 $7.19 $8.45 $8.25 $7.38 $6.83 $6.62 $7.24 $8.08 $8.08
Cash/Share $3.95 $3.19 $3.52 $3.99 $4.42 $5.18 $4.07 $2.51 $3.45 $2.78 $2.21 $4.46 $5.74 $5.39 $3.65 $3.43 $7.29 $5.85 $2.31 $2.89 $2.89
EBITDA/Share $4.76 $7.06 $7.90 $9.08 $8.51 $8.37 $7.83 $4.00 $4.84 $2.70 $3.53 $8.09 $7.57 $10.12 $10.30 $9.96 $11.07 $11.36 $7.66 $5.63 $5.63
Debt/Share $10.43 $13.66 $12.53 $12.47 $11.97 $12.55 $12.05 $14.54 $13.69 $14.20 $13.45 $14.85 $15.01 $15.06 $13.77 $14.09 $16.56 $20.31 $19.87 $21.81 $21.81
Net Debt/Share $6.48 $10.47 $9.01 $8.48 $7.54 $7.38 $7.98 $12.03 $10.25 $11.42 $11.24 $10.39 $9.26 $9.67 $10.12 $10.66 $9.27 $14.46 $17.56 $18.92 $18.92
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.631
Altman Z-Prime snapshot only 6.213
Piotroski F-Score 8 9 8 7 6 8 7 6 4 5 6 8 8 9 8 7 7 4 5 4 4
Beneish M-Score -2.76 -2.25 -2.21 -2.26 -2.50 -2.68 -2.63 -2.93 -2.94 -2.95 -2.98 -2.58 -2.66 -2.65 -2.66 -2.52 -2.34 -2.11 -2.63 -2.94 -2.937
Ohlson O-Score snapshot only -7.818
Net-Net WC snapshot only $-20.69
EVA snapshot only $-3463639441.83
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A-
Credit Score 73.60 72.87 79.77 80.39 85.39 82.77 83.79 70.36 75.30 57.58 71.43 82.63 82.96 83.57 83.58 80.67 80.42 78.47 74.91 67.81 67.809
Credit Grade snapshot only 7
Credit Trend snapshot only -12.858
Implied Spread (bps) snapshot only 175.000
Industry Credit Rank snapshot only 50
Sector Credit Rank snapshot only 68

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms